Cognition Therapeutics, Inc(CGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CGTX Cognition Therapeutics, Inc

交易中 08-24 13:49:28 EDT

0.9920

-0.0039

-0.39%

最高0.9993	最低0.9600	成交量16.07万
今开0.9900	昨收0.9959	日振幅3.95%
总市值9,433万	流通市值8,474万	总股本9,509万
成交额15.76万	换手率0.19%	流通股本8,542万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CGTX","market":"US","secType":"STK","nameCN":"Cognition Therapeutics, Inc","latestPrice":0.992,"timestamp":1787593678824,"preClose":0.9959,"halted":0,"volume":160666,"delay":0,"changeRate":-0.003916055828898498,"floatShares":85422005,"shares":95093746,"eps":-0.193621,"marketStatus":"交易中","change":-0.0039,"latestTime":"08-24 13:49:28 EDT","open":0.99,"high":0.9993,"low":0.96,"amount":157600.96507804,"amplitude":0.039462,"askPrice":0.9933,"askSize":100,"bidPrice":0.9907,"bidSize":1535,"shortable":3,"etf":0,"ttmEps":-0.193621,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"listingDate":1633665600000,"exchange":"NASDAQ","adjPreClose":0.9959,"preHourTrading":{"tag":"盘前","latestPrice":0.9721,"preClose":0.9959,"latestTime":"09:28 EDT","volume":1516,"amount":1483.2236252,"timestamp":1787578083686,"change":-0.0238,"changeRate":-0.023898,"amplitude":0.033939},"postHourTrading":{"tag":"盘后","latestPrice":1.01,"preClose":0.9959,"latestTime":"19:30 EDT","volume":802,"amount":792.2401,"timestamp":1787355006303,"change":0.0141,"changeRate":0.014158,"amplitude":0.031328},"volumeRatio":0.539856},"requestUrl":"/m/hq/s/CGTX/","defaultTab":"news","newsList":[{"id":"1129792757","title":"Cognition Therapeutics 公布2026年第二季度财报并更新业务进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1129792757","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129792757?lang=zh_cn&edition=full","pubTime":"2026-08-07 04:21","pubTimestamp":1786047662,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics, Inc 发布了2026年第二季度的财务业绩报告，同时针对公司当前业务进展进行了全面更新。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123749542","title":"Cognition Therapeutics就Zervimesine (CT1812)治疗DLB精神病关键研究关键方面与FDA达成一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1123749542","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123749542?lang=zh_cn&edition=full","pubTime":"2026-06-24 19:30","pubTimestamp":1782300645,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics, Inc (简称Cognition)宣布，在收到美国食品药品监督管理局（FDA）的正式会议纪要后，公司已就其核心候选药物Zervimesine (CT1812)用于治疗路易体痴呆（DLB）相关精神病的关键性研究的关键方面与监管机构达成一致。这一进展标志着该药物研发路径上的一个重要里程碑。公司表示，将基于这些共识，推进后续临床研究计划，旨在为这一严重未满足医疗需求的领域提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104732946","title":"Cognition Therapeutics 完成与FDA就Zervimesine (CT1812)治疗路易体痴呆伴精神病症的会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1104732946","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104732946?lang=zh_cn&edition=full","pubTime":"2026-05-21 19:31","pubTimestamp":1779363084,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics, Inc 已成功完成与美国食品药品监督管理局（FDA）就其在研药物Zervimesine (CT1812)用于治疗路易体痴呆伴精神病症适应症所举行的会议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100851859","title":"Cognition Therapeutics公布2025财年业绩报告并披露临床研发进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1100851859","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100851859?lang=zh_cn&edition=full","pubTime":"2026-03-26 19:31","pubTimestamp":1774524675,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics公司近日正式发布了截至2025年12月31日的年度财务报告，同时向投资者同步了旗下创新药物研发管线的最新临床推进动态。这份综合公告既展示了企业在财务层面的稳健表现，又揭示了其在神经退行性疾病治疗领域的前沿探索。\n通过系统性披露关键财务指标与临床里程碑事件，该公司为市场参与者提供了评估其战略执行效能与未来发展潜力的多维视角。在当前生物科技行业融资环境充满挑战的背景下，这类全面透明的信息披露显得尤为珍贵。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517100479","title":"Cognition Therapeutics, Inc.盘中异动 早盘股价大跌8.46%报0.385美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517100479","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517100479?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185055,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Cognition Therapeutics, Inc.股票出现波动，股价快速跳水8.46%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223055abe9b05a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223055abe9b05a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","CGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514830063","title":"Cognition Therapeutics, Inc.盘中异动 早盘急速跳水5.05%报0.470美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514830063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514830063?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:31","pubTimestamp":1740666664,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时31分，Cognition Therapeutics, Inc.股票出现异动，股价大幅跳水5.05%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022722310498950fed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022722310498950fed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","CGTX","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514894977","title":"Chardan Capital：维持Cognition Therapeutics(CGTX.US)评级，由买入调整至买入评级, 目标价由11.00美元调整至11.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514894977","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514894977?lang=zh_cn&edition=full","pubTime":"2025-02-27 07:17","pubTimestamp":1740611836,"startTime":"0","endTime":"0","summary":"Chardan Capital：维持Cognition Therapeutics(CGTX.US)评级，由买入调整至买入评级, 目标价由11.00美元调整至11.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27071748414473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","CGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514856377","title":"Cognition Therapeutics, Inc.盘中异动 早盘股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856377","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514856377?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:40","pubTimestamp":1740580832,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时40分，Cognition Therapeutics, Inc.股票出现波动，股价大幅拉升5.34%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022622403396315115&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022622403396315115&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CGTX","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514130650","title":"Cognition Therapeutics, Inc.盘中异动 股价大跌5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514130650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514130650?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:22","pubTimestamp":1740496963,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时22分，Cognition Therapeutics, Inc.股票出现波动，股价急速下挫5.48%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252322439892582d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252322439892582d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CGTX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512865604","title":"Cognition Therapeutics, Inc.盘中异动 早盘快速拉升5.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512865604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512865604?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:18","pubTimestamp":1739978334,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时18分，Cognition Therapeutics, Inc.股票出现异动，股价大幅上涨5.93%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219231854abd50a7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219231854abd50a7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","CGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509928232","title":"Cognition Therapeutics, Inc.盘中异动 股价大涨6.27%报0.667美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509928232","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509928232?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:31","pubTimestamp":1738765878,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时31分，Cognition Therapeutics, Inc.股票出现异动，股价急速上涨6.27%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223118abc37d52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223118abc37d52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGTX","BK4139","BK4007","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509667644","title":"Cognition Therapeutics, Inc.盘中异动 急速下挫5.75%报0.628美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509667644","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509667644?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:08","pubTimestamp":1738685327,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时08分，Cognition Therapeutics, Inc.股票出现波动，股价急速下挫5.75%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.12%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205000847abc23b7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205000847abc23b7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGTX","LENZ","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508414956","title":"Cognition Therapeutics, Inc.盘中异动 股价大跌8.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508414956","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508414956?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:32","pubTimestamp":1738593169,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时32分，Cognition Therapeutics, Inc.股票出现异动，股价急速下跌8.71%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223249a23809a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223249a23809a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGTX","BK4139","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508899448","title":"Cognition Therapeutics, Inc.盘中异动 大幅下跌5.64%报0.725美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508899448","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508899448?lang=zh_cn&edition=full","pubTime":"2025-02-01 04:20","pubTimestamp":1738354816,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日04时20分，Cognition Therapeutics, Inc.股票出现波动，股价快速下挫5.64%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201042017abbe76ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201042017abbe76ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CGTX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507622909","title":"Cognition Therapeutics, Inc.盘中异动 大幅跳水5.09%报0.722美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507622909","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507622909?lang=zh_cn&edition=full","pubTime":"2025-01-30 23:11","pubTimestamp":1738249865,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日23时11分，Cognition Therapeutics, Inc.股票出现异动，股价快速下挫5.09%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130231105abbd5408&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130231105abbd5408&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","CGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505846272","title":"Cognition Therapeutics, Inc.盘中异动 快速上涨5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505846272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505846272?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:52","pubTimestamp":1737471135,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时52分，Cognition Therapeutics, Inc.股票出现异动，股价急速上涨5.59%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.13%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121225215986e3725&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121225215986e3725&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CGTX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503284516","title":"Cognition Therapeutics, Inc.盘中异动 快速拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503284516","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503284516?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:35","pubTimestamp":1736951704,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时35分，Cognition Therapeutics, Inc.股票出现波动，股价急速上涨5.03%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223504a222ff59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223504a222ff59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CGTX","BK4007","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503586814","title":"Cognition Therapeutics, Inc.盘中异动 急速下挫5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503586814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503586814?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:31","pubTimestamp":1736778694,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时31分，Cognition Therapeutics, Inc.股票出现异动，股价快速跳水5.16%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.01%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223134960252af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223134960252af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","CGTX","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501230973","title":"Cognition Therapeutics, Inc.盘中异动 早盘大幅上涨5.59%报0.797美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501230973","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501230973?lang=zh_cn&edition=full","pubTime":"2025-01-06 22:32","pubTimestamp":1736173959,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日22时32分，Cognition Therapeutics, Inc.股票出现波动，股价急速上涨5.59%。截至发稿，该股报0.797美元/股，成交量15.5702万股，换手率0.37%，振幅1.44%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223239a217966c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223239a217966c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","CGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500412874","title":"Cognition Therapeutics, Inc.盘中异动 急速上涨5.10%报0.760美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500412874","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500412874?lang=zh_cn&edition=full","pubTime":"2025-01-04 03:18","pubTimestamp":1735931935,"startTime":"0","endTime":"0","summary":"北京时间2025年01月04日03时18分，Cognition Therapeutics, Inc.股票出现异动，股价大幅上涨5.10%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.96%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104031855985a683e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104031855985a683e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CGTX","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cogrx.com","stockEarnings":[{"period":"1week","weight":-0.014},{"period":"1month","weight":0.0351},{"period":"3month","weight":-0.2096},{"period":"6month","weight":-0.0424},{"period":"1year","weight":-0.4995},{"period":"ytd","weight":-0.2623}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cognition Therapeutics, Inc.于2007年8月21日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，专注于开发针对中枢神经系统和视网膜年龄相关性退行性疾病的小分子疗法。其主要候选药物zervimesine是一种口服疗法，旨在通过靶向蛋白寡聚体来保护神经元突触，并已在阿尔茨海默病、路易体痴呆和地图状萎缩的临床试验中进行了评估。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.060065},{"month":2,"riseRate":0,"avgChangeRate":-0.189802},{"month":3,"riseRate":0.2,"avgChangeRate":-0.073136},{"month":4,"riseRate":0.8,"avgChangeRate":0.125839},{"month":5,"riseRate":0.4,"avgChangeRate":-0.077033},{"month":6,"riseRate":0.2,"avgChangeRate":-0.035976},{"month":7,"riseRate":0.2,"avgChangeRate":0.013942},{"month":8,"riseRate":0.6,"avgChangeRate":0.599491},{"month":9,"riseRate":0,"avgChangeRate":-0.232471},{"month":10,"riseRate":0.5,"avgChangeRate":0.012004},{"month":11,"riseRate":0.2,"avgChangeRate":0.100902},{"month":12,"riseRate":0.4,"avgChangeRate":0.102692}],"exchange":"NASDAQ","name":"Cognition Therapeutics, Inc","nameEN":"Cognition Therapeutics, Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cognition Therapeutics, Inc(CGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cognition Therapeutics, Inc(CGTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cognition Therapeutics, Inc,CGTX,Cognition Therapeutics, Inc股票,Cognition Therapeutics, Inc股票老虎,Cognition Therapeutics, Inc股票老虎国际,Cognition Therapeutics, Inc行情,Cognition Therapeutics, Inc股票行情,Cognition Therapeutics, Inc股价,Cognition Therapeutics, Inc股市,Cognition Therapeutics, Inc股票价格,Cognition Therapeutics, Inc股票交易,Cognition Therapeutics, Inc股票购买,Cognition Therapeutics, Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cognition Therapeutics, Inc(CGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cognition Therapeutics, Inc(CGTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}